Jul 30, 2024 · Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.

Find the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · PTGX | Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

12 hours ago · Protagonist Therapeutics Stock Performance. PTGX stock opened at $38.88 on Monday. The stock has a market cap of $2.32 billion, a P/E ratio of 14.62 and a beta of 2.22. The firm has a 50 day ...

4 days ago · See the latest Protagonist Therapeutics Inc stock price (PTGX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

4 days ago · Should You Buy or Sell Protagonist Therapeutics Stock? Get The Latest PTGX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

Get the latest Protagonist Therapeutics Inc (PTGX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Get a real-time Protagonist Therapeutics, Inc. (PTGX) stock price quote with breaking news, financials, statistics, charts and more.

Discover real-time Protagonist Therapeutics, Inc. Common Stock (PTGX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...

Complete Protagonist Therapeutics Inc. stock information by Barron's. View real-time PTGX stock price and news, along with industry-best analysis.